Protagonist Therapeutics
PTGX
PTGX
61 hedge funds and large institutions have $165M invested in Protagonist Therapeutics in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 26 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
-8
Holders Change %
-11.59%
% of All Funds
1.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
20
Reduced
26
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$13.7M |
2 |
BI
BVF Inc
San Francisco,
California
|
+$12.3M |
3 |
Millennium Management
New York
|
+$8.29M |
4 |
Jennison Associates
New York
|
+$3.6M |
5 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
+$2.85M |